Fairman Group, LLC

SEC CIK: 0002016719
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Fairman Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overview All 13F holders of DFTX Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of DFTX by Fairman Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−85−100.0%	Sold out	Holders
Q1 2024	85	$799	<0.1%	00.0%	Unchanged	Holders
Q4 2023	85	$311	<0.1%	–	No prior filing	Holders